Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report.
Although the FIT has a number of advantages over the guaiac-based fecal occult blood test [22-27], one notable feature is the ability to provide quantitative estimates of fecal hemoglobin.
These include 2 fecal occult blood only tests, which can be guaiac-based (gFOBT) (only the high-sensitivity gFOBT is acceptable for screening) or immunochemical-based (FIT).
* asymptomatic (no signs or symptoms of colorectal disease including but not limited to lower gastrointestinal pain, blood in stool, positive guaiac fecal occult blood test or fecal immunochemical test), and
In this issue of the Journal, Kok and colleagues (4) report a study on the diagnostic accuracy of point-of-care tests (POCTs) (6) for fecal calprotectin and occult blood in primary care and assessing what they term "organic bowel disease." A qualitative immunochemical fecal occult blood test was used.
Among the topics are hereditary colorectal cancer and polyp syndromes, behavior and dietary modification in prevention, fecal occult blood test, colonoscopy and flexible sigmoidoscopy in colorectal cancer screening and surveillance, radiological techniques for virtual colonoscopy, open surgical techniques, systemic therapy, why to participate in clinical trials, vaccines and immunotherapy, and coping with colorectal cancer.
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.